INVO Fertility Inc surges amid strong market performance
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 20 Jan 26
Source: 8-K
INVO Fertility Inc's stock price has surged by 231.12% in pre-market trading, crossing above its 5-day SMA, indicating a significant upward momentum.
The surge in INVO's stock price is attributed to broad market strength, with the Nasdaq-100 and S&P 500 both showing gains of 0.60% and 0.20%, respectively. This positive market environment has likely contributed to investor confidence in INVO Fertility Inc.
As the market continues to show strength, INVO Fertility Inc may attract further investor interest, potentially leading to continued upward movement in its stock price.
Analyst Views on IVF
About IVF
INVO Fertility Inc., formerly NAYA Biosciences, Inc., is a healthcare services company focused on the fertility marketplace and expanding access to assisted reproductive technology (ART) care for patients in need. Its segments include Fertility Clinic Services, INVOcell Device, and Therapeutics. It focuses on operating fertility clinics, including INVO Centers dedicated primarily to offering the intravaginal culture (IVC) procedure enabled by its INVOcell medical device (INVOcell) and United States-based, in vitro fertilization (IVF) clinics. It has two operational INVO Centers in the United States and one IVF clinic. It is also engaged in the sale and distribution of its INVOcell technology solution to third party-owned and operated fertility clinics. The INVOcell is a proprietary medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The IVC procedure provides patients with a natural, intimate, and affordable experience.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
